Tracking Retinal Health With Wearable Technology - Takeaways - MDSpire

Tracking Retinal Health With Wearable Technology

The use of wearable devices for health monitoring has attracted significant interest from patients, physicians, and other healthcare professionals because of their potential to usher in a new era of personalized, accessible, and convenient care. This article explores the use of wearable technology for monitoring retinal health, both through direct assessment of ocular parameters—such as visual field testing and imaging—and through systemic monitoring of surrogate markers of retinal health.

  • By

  • Raj Kundu, BS

  • Sharon Fekrat, MD, FASRS

  • January 1, 2026

  • 12 min

Share

  • 1

    Wearable technology offers real-time monitoring of ocular and systemic markers of retinal health, enhancing personalized patient care.

  • 2

    VR-based perimetry provides a cost-effective alternative for visual field testing but faces challenges like technical standardization and user familiarity.

  • 3

    The OcuLenz AR headset assists patients with age-related macular degeneration by shifting imagery away from central scotomas to improve vision.

  • 4

    Wearable OCT devices aim to enhance accessibility for retinal imaging, potentially allowing remote monitoring of ocular and systemic diseases.

  • 5

    Continuous glucose monitoring technology improves diabetes management, which is crucial for preventing diabetic retinopathy.

Original Source(s)

Tracking Retinal Health With Wearable Technology

  • by Raj Kundu, BS, Sharon Fekrat, MD, FASRS

  • January 1, 2026

Related Content

Correlation between cardiorespiratory fitness and body composition in individuals with different glucose metabolism statuses

Side Effects: They Googled It

Patients are mining Reddit and TikTok for symptom intel while you're not — and a small study calls it epistemic injustice. Different knowledge, mutually unrecognized. Maybe ask where they've been reading before you wave it off as anecdote.

Establishment and validation of a machine learning-based predictive model for in-hospital mortality risk in acute myocardial infarction patients complicated with diabetes mellitus